Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer
- 1 October 2006
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 66 (2) , 408-415
- https://doi.org/10.1016/j.ijrobp.2006.04.049
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- SURVIVAL OF PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN ERAJournal of Urology, 2004
- Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic reviewHealth Technology Assessment, 2003
- High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patientsInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate CancerJNCI Journal of the National Cancer Institute, 1999
- Comparison of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy systemsSeminars in Radiation Oncology, 1999
- Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Primer on Medical Decision Analysis: Part 5—Working with Markov ProcessesMedical Decision Making, 1997
- Markov Models in Medical Decision MakingMedical Decision Making, 1993
- A Decision Analysis of Alternative Treatment Strategies for Clinically Localized Prostate CancerPublished by American Medical Association (AMA) ,1993
- The Markov Process in Medical PrognosisMedical Decision Making, 1983